Here are five key points:
1. The CMS also added the insertion of interspinous spacers to the list of approved surgical procedures in ASCs, starting Jan. 1, 2016.
2. The Superion Interspinous Spacer System is a minimally invasive spinal implant.
3. The implant is intended to treat lumbar spinal stenosis and designed to decrease pressure on the affected nerves.
4. The device has been implanted in more than 2,000 patients globally.
5. Superion Interspinous received FDA PMA Approval in May 2015.
“The transition to a Category I code will erase the longstanding uncertainty associated with coverage and payment of Category III codes for facilities, physicians and patients,” said Earl R. Fender, president and CEO, VertiFlex. “The inclusion of Superion’s minimally invasive procedure in ASCs will afford Medicare beneficiaries access to care.”
More articles on devices:
Medovex enters consulting agreement with spine surgeon Dr. Vik Kapoor: 5 key notes
DJO Global Q3 net sales see slight decline, surgical implants up 58%: 5 key notes
AxiaLIF could save $3.5k per spine surgery: 5 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
